Pharma
Global Veterinary Anti-Infectives Market Opportunities and Forecast 2020-2027
  • DLR2958
  • 12 March, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Veterinary Anti-Infectives Market, By Drug Class (Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Antiparasitic Agents, Others) By Distribution Channel (Veterinary Hospitals, Pharmacies, Others), and opportunities and forecast 2020-2027

Veterinary Anti-Infectives Market Overview

The global veterinary anti-infectives market is expected to grow at significant rate in the estimated period.  The rise in the number of occurrences of various types of animal health problems has resulted in a surge in the need for veterinary anti-infectives in many regions of the world. There has been a significant increase in awareness of numerous health conditions identified in pets and livestock over the last few years. This circumstance has resulted in a significant increase in the use of veterinary anti-infectives.
 
Furthermore, in order to meet the ever-increasing demand for diverse animal-based products such as fresh meat, dairy products, and dietary nutrition, livestock owners are increasingly focusing on sustaining veterinary health standards. Aside from that, livestock owners are more aware of the importance of animal immunizations. In the next years, all of these factors are projected to lead to a greater acceptance of veterinary anti-infectives. Eventually it boosts the growth of the Global Veterinary Anti-Infectives Market at a large extend.

Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Drug Class, Distribution Channel, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Phibro Animal Health Corporation, Intas Pharmaceuticals, Inc., Zoetis, Inc., Heska Corporation, and Ceva Sante Animale.


Covid-19 Impact on Veterinary Anti-Infectives Market
 
In addition, the current Veterinary Anti-Infectives Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Veterinary Anti-Infectives Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Veterinary Anti-Infectives Market Segment Overview



According to Distribution Channel, Veterinary Hospitals segment holds the largest share of the global Veterinary Anti-Infectives Market. Moreover, the global veterinary anti-infectives market's companies are putting more effort into increasing their businesses. Major industrial players are boosting their research and development investments in the next years. This strategy helps companies in improving the quality of the products. As a result of all of these initiatives, the veterinary anti-infectives market is expected to see significant growth in the future years.
 
Veterinary Anti-Infectives Market, By Drug Class
·       Antimicrobial Agents
·       Antiviral Agents
·       Antifungal Agents
·       Antiparasitic Agents
·       Others

Veterinary Anti-Infectives Market, By Distribution Channel
·       Veterinary Hospitals
·       Pharmacies
·       Others

Veterinary Anti-Infectives Market Regional Overview

In terms of region, North America is most prominent region for the global Veterinary Anti-Infectives Market. This is due  to the increasing demand for nutrition along with increased ownership in this region. Furthermore, pet insurance is a common practise in the region, as it helps in the provision of essential animal needs. Additionally, in the coming years, the Asia Pacific region is anticipated to become the fastest growing market. The region is being helped by the promotion of small animal care and actions conducted by various governmental bodies.

Veterinary Anti-Infectives Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Veterinary Anti-Infectives Market Competitor overview

Some key developments and strategies adopted by manufacturers in Veterinary Anti-Infectives are highlighted below.

·       In January 2022, Dechra is pleased to announce the acquisition of the veterinary approved Isoflurane®, USP Inhalant Anesthetic and Sevoflurane®, USP Inhalant Anesthetic from Halocarbon. Dechra will be launching the veterinary branded Isoflurane and Sevoflurane in the first quarter of 2022.

Veterinary Anti-Infectives Market, Key Players

·       Phibro Animal Health Corporation
·       Intas Pharmaceuticals, Inc.
·       Zoetis, Inc.
·       Heska Corporation
·       Ceva Sante Animale

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the global Veterinary Anti-Infectives market?

A. The rise in the number of occurrences of various types of animal health problems has resulted in a surge in the need for veterinary anti-infectives in many regions of the world. This is one of the key factors boosting the growth of the Veterinary Anti-Infectives market.

Q2. Which Segments are covered in the global Veterinary Anti-Infectives market report?

A. Drug Class, Distribution Channel, and Region. these segments are covered in the global Veterinary Anti-Infectives market report.

Q3. Which segment is projected to hold the largest share in the global Veterinary Anti-Infectives market?

A. Veterinary Hospitals segment is projected to hold the largest share in the global Veterinary Anti-Infectives market.

Q4. Which region holds the largest share in the global Veterinary Anti-Infectives market?

A. North America holds the largest share in the global Veterinary Anti-Infectives market.

Q5. Which are the prominent players in the global Veterinary Anti-Infectives market?

A. Phibro Animal Health Corporation, Intas Pharmaceuticals, Inc., Zoetis, Inc., Heska Corporation, and Ceva Sante Animale. are some key players in the global Veterinary Anti-Infectives market.
Veterinary Anti-Infectives Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Veterinary Anti-Infectives Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Drug Class
        • 5.2.1. Antimicrobial Agents
        • 5.2.2. Antiviral Agents
        • 5.2.3. Antifungal Agents
        • 5.2.4. Antiparasitic Agents
        • 5.2.5. Others
      • 5.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 5.3.1. Veterinary Hospitals
        • 5.3.2. Pharmacies
        • 5.3.3. Others
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America Veterinary Anti-Infectives Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Drug Class
        • 6.2.1. Antimicrobial Agents
        • 6.2.2. Antiviral Agents
        • 6.2.3. Antifungal Agents
        • 6.2.4. Antiparasitic Agents
        • 6.2.5. Others
      • 6.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 6.3.1. Veterinary Hospitals
        • 6.3.2. Pharmacies
        • 6.3.3. Others
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Veterinary Anti-Infectives Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Drug Class
        • 7.2.1. Antimicrobial Agents
        • 7.2.2. Antiviral Agents
        • 7.2.3. Antifungal Agents
        • 7.2.4. Antiparasitic Agents
        • 7.2.5. Others
      • 7.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 7.3.1. Veterinary Hospitals
        • 7.3.2. Pharmacies
        • 7.3.3. Others
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Veterinary Anti-Infectives Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Drug Class
        • 8.2.1. Antimicrobial Agents
        • 8.2.2. Antiviral Agents
        • 8.2.3. Antifungal Agents
        • 8.2.4. Antiparasitic Agents
        • 8.2.5. Others
      • 8.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 8.3.1. Veterinary Hospitals
        • 8.3.2. Pharmacies
        • 8.3.3. Others
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Veterinary Anti-Infectives Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Drug Class
        • 9.2.1. Antimicrobial Agents
        • 9.2.2. Antiviral Agents
        • 9.2.3. Antifungal Agents
        • 9.2.4. Antiparasitic Agents
        • 9.2.5. Others
      • 9.3. Market Analysis, Insights and Forecast – By Distribution Channel
        • 9.3.1. Veterinary Hospitals
        • 9.3.2. Pharmacies
        • 9.3.3. Others
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Phibro Animal Health Corporation
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Intas Pharmaceuticals, Inc.
      • 10.6. Zoetis, Inc.
      • 10.7. Heska Corporation

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      [email protected]

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934